Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PTC THERAPEUTICS, INC.PTCT · Entity 3803 | CHIEF TECHNICAL OPS OFFICER | July 09, 2026 | July 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PTC THERAPEUTICS, INC.
Report date July 09, 2026 · Filed July 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 60,299 |
Ending reported balance
After 2026-07-09 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-07-09 · Exercise / conversion · Acquired 2,464 · Balance 62,763 F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. Row 2 · 2026-07-09 · Sale · Disposed 2,464 · Balance 60,299 F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. F2: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $90.00 to $90.70 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.54 · Expires 2035-01-02 | Direct | 45,036 |
Reported balance
After 2026-07-09 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-07-09 · Exercise / conversion · Disposed 2,464 · Balance 45,036 F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. F3: This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026. |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 2,899 |
Reported balance
Holding disclosure · report date 2026-07-09 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 2,899 |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025.
F2: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $90.00 to $90.70 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F3: This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 24, 2023 Filed Jan 26, 2023 21:20 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 44 | $47.45 | $2,087.86 |
DisclosureSEC source: 0001415889-23-001458 · form4-01262023_090125.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 3,287 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 143 RSUs from a January 22, 2019 grant of 570 RSUs. Read SEC document |
| January 11, 2023 Filed Jan 12, 2023 21:39 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 27 | $44.36 | $1,197.71 |
DisclosureSEC source: 0001415889-23-000884 · form4-01122023_090120.xml · nonDerivative · entry 4 Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 3,331 F2 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 195 RSUs from a January 7, 2022 grant of 780 RSUs. Read SEC document |
| January 11, 2023 Filed Jan 12, 2023 21:39 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 383 | $44.36 | $16,989.73 |
DisclosureSEC source: 0001415889-23-000884 · form4-01122023_090120.xml · nonDerivative · entry 3 Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,579 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 3,600 RSUs from a January 7, 2022 grant of 14,400 RSUs. Read SEC document |
| January 10, 2023 Filed Jan 12, 2023 21:39 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 27 | $42.93 | $1,159.19 |
DisclosureSEC source: 0001415889-23-000884 · form4-01122023_090120.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 3,358 F2 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 195 RSUs from a January 7, 2022 grant of 780 RSUs. Read SEC document |
| January 10, 2023 Filed Jan 12, 2023 21:39 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 473 | $42.93 | $20,307.26 |
DisclosureSEC source: 0001415889-23-000884 · form4-01122023_090120.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,962 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 3,600 RSUs from a January 7, 2022 grant of 14,400 RSUs. Read SEC document |
| January 09, 2023 Filed Jan 11, 2023 23:16 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 43 | $41.66 | $1,791.22 |
DisclosureSEC source: 0001415889-23-000839 · form4-01112023_110131.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 3,385 F2 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 150 RSUs from a January 6, 2021 grant of 600 RSUs. Read SEC document |
| January 09, 2023 Filed Jan 11, 2023 23:16 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 716 | $41.66 | $29,825.84 |
DisclosureSEC source: 0001415889-23-000839 · form4-01112023_110131.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,435 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,550 RSUs from a January 6, 2021 grant of 10,200 RSUs. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 21:58 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantStock Option (Right to Buy) · Derivative | 36,250 | $0.00 Strike: $39.42 | $0.00 |
DisclosureSEC source: 0001415889-23-000693 · form4-01092023_090150.xml · derivative · entry 3 Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,250 Underlying: Common Stock · 36,250 shares Expires 2033-01-04 F3 · derivative.exercise_date: This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 21:58 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantCommon Stock | 710 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-000693 · form4-01092023_090150.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 3,428 F1 · shares: Restricted stock units granted on January 5, 2023 that vest in four equal installments over four years, commencing on January 5, 2024. F2 · balance_after: Includes 298 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2022. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 21:58 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantCommon Stock | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-000693 · form4-01092023_090150.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,151 F1 · shares: Restricted stock units granted on January 5, 2023 that vest in four equal installments over four years, commencing on January 5, 2024. F2 · balance_after: Includes 298 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2022. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:57 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 27 | $40.00 | $1,080.05 |
DisclosureSEC source: 0001179110-22-000835 · edgar.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 2,420 F2 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 93 RSUs from a January 29, 2020 grant of 370 RSUs. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:57 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 605 | $40.00 | $24,201.21 |
DisclosureSEC source: 0001179110-22-000835 · edgar.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,853 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,550 RSUs from a January 29, 2020 grant of 10,200 RSUs. Read SEC document |
| January 25, 2022 Filed Jan 27, 2022 21:01 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 43 | $39.31 | $1,690.50 |
DisclosureSEC source: 0001179110-22-000628 · edgar.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 2,447 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 142 RSUs from a January 22, 2019 grant of 570 RSUs. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:20 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantStock Option (Right to Buy) · Derivative | 54,000 | $0.00 Strike: $38.10 | $0.00 |
DisclosureSEC source: 0001179110-22-000400 · edgar.xml · derivative · entry 5 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,000 Underlying: Common Stock · 54,000 shares Expires 2032-01-06 F4 · derivative.exercise_date: This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:20 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantCommon Stock | 780 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000400 · edgar.xml · nonDerivative · entry 4 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 2,490 F2 · shares: Restricted stock units granted on January 7, 2022 that vest in four equal installments over four years, commencing on January 7, 2023. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:20 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 45 | $38.53 | $1,733.63 |
DisclosureSEC source: 0001179110-22-000400 · edgar.xml · nonDerivative · entry 3 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 1,710 F3 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 150 RSUs from a January 6, 2021 grant of 600 RSUs. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:20 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantCommon Stock | 14,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000400 · edgar.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,458 F2 · shares: Restricted stock units granted on January 7, 2022 that vest in four equal installments over four years, commencing on January 7, 2023. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:20 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 756 | $38.53 | $29,124.90 |
DisclosureSEC source: 0001179110-22-000400 · edgar.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,058 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,550 RSUs from a January 6, 2021 grant of 10,200 RSUs. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 21:10 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 64 | $41.16 | $2,634.37 |
DisclosureSEC source: 0001179110-22-000305 · edgar.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 1,755 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 219 RSUs from a January 3, 2018 grant of 874 RSUs. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 23:22 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 28 | $56.96 | $1,594.77 |
DisclosureSEC source: 0001179110-21-001095 · edgar.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 1,819 F2 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 92 RSUs from a January 29, 2020 grant of 370 RSUs. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 23:22 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 973 | $56.96 | $55,418.19 |
DisclosureSEC source: 0001179110-21-001095 · edgar.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,814 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,550 RSUs from a January 29, 2020 grant of 10,200 RSUs. Read SEC document |
| January 25, 2021 Filed Jan 27, 2021 21:26 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 44 | $62.05 | $2,730.38 |
DisclosureSEC source: 0001179110-21-000875 · edgar.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 1,847 F2 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 143 RSUs from a January 22, 2019 grant of 570 RSUs. Read SEC document |
| January 25, 2021 Filed Jan 27, 2021 21:26 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 497 | $63.25 | $31,435.25 |
DisclosureSEC source: 0001179110-21-000875 · edgar.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 1,891 F1 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the spouse of the Reporting Person on November 10, 2020. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 21:18 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,300 | $27.05 Strike: $27.05 | $35,165.00 |
DisclosureSEC source: 0001179110-21-000540 · edgar.xml · derivative · entry 3 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Common Stock · 1,300 shares Expires 2024-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the spouse of the Reporting Person on November 10, 2020. F2 · derivative.exercise_date: Currently exercisable. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 21:18 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 1,300 | $69.00 | $89,700.00 |
DisclosureSEC source: 0001179110-21-000540 · edgar.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 2,388 F1 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the spouse of the Reporting Person on November 10, 2020. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 21:18 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 1,300 | $27.05 | $35,165.00 |
DisclosureSEC source: 0001179110-21-000540 · edgar.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 3,688 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the spouse of the Reporting Person on November 10, 2020. Read SEC document |
| January 06, 2021 Filed Jan 8, 2021 22:11 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantStock Option (Right to Buy) · Derivative | 59,500 | $0.00 Strike: $66.49 | $0.00 |
DisclosureSEC source: 0001179110-21-000466 · edgar.xml · derivative · entry 3 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,500 Underlying: Common Stock · 59,500 shares Expires 2031-01-05 F2 · derivative.exercise_date: This option was granted on January 6, 2021, and vests over four years, with 25% of the shares underlying the option vesting on January 6, 2022, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 6, 2022. Read SEC document |
| January 06, 2021 Filed Jan 8, 2021 22:11 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantCommon Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-000466 · edgar.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 2,388 F1 · shares: Restricted stock units granted on January 6, 2021 that vest in four equal installments over four years, commencing on January 6, 2022. Read SEC document |
| January 06, 2021 Filed Jan 8, 2021 22:11 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantCommon Stock | 10,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-000466 · edgar.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,787 F1 · shares: Restricted stock units granted on January 6, 2021 that vest in four equal installments over four years, commencing on January 6, 2022. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 21:54 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 68 | $62.37 | $4,241.16 |
DisclosureSEC source: 0001179110-21-000411 · edgar.xml · nonDerivative · entry 3 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 1,788 F3 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 218 RSUs from a January 3, 2018 grant of 874 RSUs. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 21:54 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 56 | $62.37 | $3,492.72 |
DisclosureSEC source: 0001179110-21-000411 · edgar.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 1,856 F2 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 180 RSUs from a January 3, 2017 grant of 720 RSUs. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 21:54 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 502 | $62.37 | $31,309.74 |
DisclosureSEC source: 0001179110-21-000411 · edgar.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,587 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,500 shares of restricted stock from a January 3, 2017 grant of 6,000 shares of restricted stock. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right to Buy) · Derivative | 600 | $10.85 Strike: $10.85 | $6,510.00 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · derivative · entry 31 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Common Stock · 600 shares Expires 2023-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the spouse of the Reporting Person on November 10, 2020. F13 · derivative.exercise_date: Currently exercisable. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right to Buy) · Derivative | 48,125 | $18.01 Strike: $18.01 | $866,731.25 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · derivative · entry 30 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 48,125 shares Expires 2028-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 24, 2020. F14 · derivative.exercise_date: This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right to Buy) · Derivative | 187 | $18.01 Strike: $18.01 | $3,367.87 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · derivative · entry 29 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,625 Underlying: Common Stock · 187 shares Expires 2028-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 24, 2020. F14 · derivative.exercise_date: This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,715 | $11.23 Strike: $11.23 | $64,179.45 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · derivative · entry 28 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,715 shares Expires 2027-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 10, 2020. F13 · derivative.exercise_date: Currently exercisable. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right To Buy) · Derivative | 4,188 | $18.01 Strike: $18.01 | $75,425.88 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · derivative · entry 27 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,812 Underlying: Common Stock · 4,188 shares Expires 2028-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 24, 2020. F14 · derivative.exercise_date: This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,188 | $11.23 Strike: $11.23 | $24,571.24 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · derivative · entry 26 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,715 Underlying: Common Stock · 2,188 shares Expires 2027-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 10, 2020. F13 · derivative.exercise_date: Currently exercisable. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,035 | $11.23 Strike: $11.23 | $34,083.05 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · derivative · entry 25 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,903 Underlying: Common Stock · 3,035 shares Expires 2027-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 10, 2020. F13 · derivative.exercise_date: Currently exercisable. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right to Buy) · Derivative | 32,771 | $27.05 Strike: $27.05 | $886,455.55 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · derivative · entry 24 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 32,771 shares Expires 2024-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 24, 2020. F13 · derivative.exercise_date: Currently exercisable. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right To Buy) · Derivative | 7,229 | $27.05 Strike: $27.05 | $195,544.45 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · derivative · entry 23 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,771 Underlying: Common Stock · 7,229 shares Expires 2024-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 24, 2020. F13 · derivative.exercise_date: Currently exercisable. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 600 | $60.65 | $36,390.00 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · nonDerivative · entry 22 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 1,912 F12 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the spouse of the Reporting Person on November 10, 2020. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 600 | $10.85 | $6,510.00 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · nonDerivative · entry 21 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 2,512 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the spouse of the Reporting Person on November 10, 2020. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 189 | $61.24 | $11,574.36 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · nonDerivative · entry 20 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,089 F1 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 24, 2020. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 47,936 | $60.58 | $2,903,723.20 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · nonDerivative · entry 19 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,278 F1 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 24, 2020. F11 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $60.18 to $61.12 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 48,125 | $18.01 | $866,731.25 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · nonDerivative · entry 18 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,214 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 24, 2020. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 187 | $60.61 | $11,333.70 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · nonDerivative · entry 17 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,089 F1 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 24, 2020. F10 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $60.40 to $61.24 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 187 | $18.01 | $3,367.87 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · nonDerivative · entry 16 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 24, 2020. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 100 | $61.24 | $6,124.00 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · nonDerivative · entry 15 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,089 F5 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 10, 2020. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 5,615 | $60.56 | $340,044.40 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · nonDerivative · entry 14 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,189 F5 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 10, 2020. F9 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $60.20 to $61.07 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.